PMI SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 3, 2026

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Picard Medical, Inc. (PMI) due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status set for April 3, 2026 [1] Group 1: Allegations Against Picard Medical - The complaint alleges that Picard Medical and its executives made false and misleading statements and failed to disclose critical information [1] - Specific allegations include involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals [1] - It is also claimed that insiders used offshore or nominee accounts to facilitate coordinated share dumping during a price inflation campaign [1] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity affecting the stock price [1] Group 2: Stock Performance - On October 24, 2025, Picard Medical shares closed at $5.31, a significant drop from $13.20 on October 23, 2025, representing a decrease of $7.89 per share or approximately 59.8% in a single session [1] - This decline marks one of the most significant one-day drops since the company's recent IPO [1] Group 3: Legal Proceedings - The court-appointed lead plaintiff will be the investor with the largest financial interest in the relief sought by the class, who will oversee the litigation on behalf of the class members [1] - Any member of the putative class can move to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [1] - Faruqi & Faruqi, LLP encourages individuals with information regarding Picard Medical's conduct to come forward, including whistleblowers and former employees [1]